癌症免疫治疗中的阿尔法病毒
1Pan Therapeutics, Lutry, Switzerland.
International review of cell and molecular biology
|August 4, 2023
概括
阿尔法病毒载体在癌症治疗,免疫疗法和疫苗中表现有前途,通过利用自我复制RNA来实现高基因表达. 临床前研究表明瘤回归和免疫反应,早期临床试验显示了良好的安全性.
科学领域:
- 病毒学 病毒学
- 在瘤学瘤学.
- 基因治疗 基因治疗
背景情况:
- 阿尔法病毒是RNA病毒,经常用于癌症应用.
- 它们通过自我放大RNA基因组提供高转基因表达.
- 阿尔法病毒载体可以用作病毒颗粒,型病毒或RNA/DNA复制品.
研究的目的:
- 审查阿尔法病毒载体在癌症治疗,免疫治疗和疫苗开发中的应用.
- 突出基于阿尔法病毒的癌症策略的机制和证明的有效性.
- 讨论阿尔法病毒在临床癌症环境中的潜力和局限性.
主要方法:
- 工程阿尔法病毒载体以表达治疗性基因 (抗瘤,细胞毒性,自杀).
- 利用阿尔法病毒载体来表达免疫刺激基因 (细胞因子,化学因子) 用于免疫治疗.
- 在癌症疫苗开发中使用α病毒载体来表达瘤抗原.
主要成果:
- 阿尔法病毒载体在临床前癌症模型中显示出显著的瘤回归和根除.
- 用阿尔法病毒载体进行免疫接种引发了强大的免疫反应和对瘤挑战的保护.
- 临床试验表明,在癌症患者中,基于阿尔法病毒的疗法具有良好的安全性和耐受性.
结论:
- 阿尔法病毒载体是用于癌症治疗,免疫治疗和疫苗开发的多功能工具.
- 临床前数据强烈支持他们的潜力,显示瘤回归和免疫刺激.
- 虽然安全,但需要进一步优化,以提高基于阿尔法病毒的癌症治疗的治疗疗效.
相关概念视频
Cancer Vaccines
403
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
403
Tumor Immunotherapy
557
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
557
Mechanisms of Retrovirus-induced Cancers
5.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K


